GENEVA, Sept. 24 -- DNA PLUS VACCINES COMPANY LIMITED filed a patent application (US2026/018743) for “THERAPEUTIC HEPATITIS B VACCINE COMPOSITION AND METHOD OF USE THEREOF”. With publication no. WO/2026/198303, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/29
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....